home / stock / ardx / ardx quote
$0.6574 Last:
6.88% Change Percent:
$0.64 Open:
$0.6574 Previous Close:
$0.6679 High:
$0.6 Low:
1,629,477 Volume:
05/27/2022 04:53:25 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2022-05-27 | 0.64 | 0.6574 | 0.6679 | 0.6 | 1,629,477 |
2022-05-26 | 0.6056 | 0.6151 | 0.647 | 0.6006 | 2,331,140 |
2022-05-25 | 0.6155 | 0.6054 | 0.62 | 0.591 | 1,110,990 |
2022-05-24 | 0.63 | 0.595 | 0.6438 | 0.5812 | 2,019,557 |
2022-05-23 | 0.655 | 0.63 | 0.66 | 0.6235 | 1,228,745 |
2022-05-20 | 0.6765 | 0.6532 | 0.69 | 0.62 | 1,431,934 |
2022-05-19 | 0.6751 | 0.675 | 0.6994 | 0.655 | 2,023,093 |
2022-05-18 | 0.6832 | 0.6578 | 0.6999 | 0.6552 | 1,637,948 |
2022-05-17 | 0.6601 | 0.694 | 0.6999 | 0.65 | 1,674,419 |
2022-05-16 | 0.6819 | 0.6461 | 0.6899 | 0.6401 | 1,945,388 |
2022-05-13 | 0.675 | 0.6531 | 0.6991 | 0.6401 | 2,094,964 |
2022-05-12 | 0.5939 | 0.6438 | 0.6665 | 0.59 | 2,200,454 |
2022-05-11 | 0.7 | 0.58 | 0.7018 | 0.577 | 3,788,388 |
2022-05-10 | 0.72 | 0.7234 | 0.765 | 0.7 | 1,654,146 |
2022-05-09 | 0.7977 | 0.7162 | 0.7977 | 0.7101 | 2,526,114 |
2022-05-06 | 0.8026 | 0.8101 | 0.8158 | 0.761 | 3,243,392 |
2022-05-05 | 0.94 | 0.8375 | 0.94 | 0.81 | 2,153,482 |
2022-05-04 | 0.9 | 0.9073 | 0.9397 | 0.8534 | 2,520,614 |
2022-05-03 | 0.83 | 0.891 | 0.9014 | 0.83 | 3,196,165 |
2022-05-02 | 0.8 | 0.8382 | 0.8498 | 0.7827 | 2,087,320 |
News, Short Squeeze, Breakout and More Instantly...
Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults PR Newswire Three poster presentations continue to highlight the safety and efficacy of IBSRELA based on data from two Phase 3 trials in adults with irritable...
3 Penny Stocks That Investors Are Buying in May 2022 With May proving to be another interesting month for penny stocks and blue chips, there is a lot that investors need to keep track of. First and foremost, we know that penny stocks are in an extremely volatile place right now. Thi...
Ardelyx Announces Additional Data Supporting the Efficacy and Safety of First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at DDW 2022 PR Newswire WALTHAM, Mass. , May 17, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharma...